Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Biol Pharm Bull ; 39(7): 1224-30, 2016 Jul 01.
Article in English | MEDLINE | ID: mdl-27150432

ABSTRACT

Radiosensitizers are used in cancer therapy to increase the γ-irradiation susceptibility of cancer cells, including radioresistant hypoxic cancer cells within solid tumors, so that radiotherapy can be applied at doses sufficiently low to minimize damage to adjacent normal tissues. Radiation-induced DNA damage is repaired by multiple repair systems, and therefore these systems are potential targets for radiosensitizers. We recently reported that the transient receptor potential vanilloid type 1 (TRPV1) channel is involved in early responses to DNA damage after γ-irradiation of human lung adenocarcinoma A549 cells. Therefore, we hypothesized that TRPV1 channel inhibitors would have a radiosensitizing effect by blocking repair of radiation-induced cell damage. Here, we show that pretreatment of A549 cells with the TRPV1 channel inhibitors capsazepine, AMG9810, SB366791 and BCTC suppressed the γ-ray-induced activation of early DNA damage responses, i.e., activation of the protein kinase ataxia-telangiectasia mutated (ATM) and accumulation of p53-binding protein 1 (53BP1). Further, the decrease of survival fraction at one week after γ-irradiation (2.0 Gy) was enhanced by pretreatment of cells with these inhibitors. On the other hand, inhibitor pretreatment did not affect cell viability, the number of apoptotic or necrotic cells, or DNA synthesis at 24 h after irradiation. These results suggest that inhibition of DNA repair by TRPV1 channel inhibitors in irradiated A549 cells caused gradual loss of proliferative ability, rather than acute facilitation of apoptosis or necrosis. TRPV1 channel inhibitors could be novel candidates for radiosensitizers to improve the efficacy of radiation therapy, either alone or in combination with other types of radiosensitizers.


Subject(s)
Gamma Rays , Radiation-Sensitizing Agents/pharmacology , TRPV Cation Channels/antagonists & inhibitors , Acrylamides/pharmacology , Anilides/pharmacology , Animals , Apoptosis/drug effects , Apoptosis/radiation effects , Bridged Bicyclo Compounds, Heterocyclic/pharmacology , Capsaicin/analogs & derivatives , Capsaicin/pharmacology , Cell Line, Tumor , Cell Survival/drug effects , Cell Survival/radiation effects , Cinnamates/pharmacology , DNA Damage/drug effects , Humans , Mice , Necrosis/chemically induced , Neoplasms/metabolism , Pyrazines/pharmacology , Pyridines/pharmacology , TRPV Cation Channels/metabolism
2.
F1000Res ; 5: 165, 2016.
Article in English | MEDLINE | ID: mdl-26998236

ABSTRACT

Recent accumulation of sequence and structural data, in conjunction with systematical classification into a set of families, has significantly advanced our understanding of diverse and specific protein functions. Analysis and interpretation of protein family data requires comprehensive sequence and structural alignments. Here, we present a simple scheme for analyzing a set of experimental structures of a given protein or family of proteins, using microbial rhodopsins as an example. For a data set comprised of around a dozen highly similar structures to each other (overall pairwise root-mean-squared deviation < 2.3 Å), intramolecular distance scoring analysis yielded valuable information with respect to structural properties, such as differences in the relative variability of transmembrane helices. Furthermore, a comparison with recent results for G protein-coupled receptors demonstrates how the results of the present analysis can be interpreted and effectively utilized for structural characterization of diverse protein families in general.

3.
J Toxicol Sci ; 39(1): 15-23, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24418705

ABSTRACT

We previously showed that nucleotide P2 receptor agonists such as ATP and UTP amplify γ-ray-induced focus formation of phosphorylated histone H2A variant H2AX (γH2AX), which is considered to be an indicator of DNA damage so far, by activating purine P2Y6 and P2Y12 receptors. Therefore, we hypothesized that these P2 receptors play a role in inducing the repair response to γ-ray-induced DNA damage. In the present study, we tested this idea by using human lung cancer A549 cells. First, reverse-transcription polymerase chain reaction (RT-PCR) showed that P2Y6 receptor is highly expressed in A549 cells, but P2Y12 receptor is only weakly expressed. Next, colony formation assay revealed that P2Y6 receptor antagonist MRS2578 markedly reduced the survival rate of γ-ray-exposed A549 cells. The survival rate was also significantly reduced in P2Y6-knock-down cells, compared with scramble siRNA-transfected cells. Since it has reported that phosphorylation of ERK1/2 after activation of EGFR via P2Y6 and P2Y12 receptors is involved in the repair response to γ-ray-induced DNA damage, we next examined whether γ-ray-induced phosphorylation of ERK1/2 was also inhibited by MRS2578 in A549 cells. We found that it was. Taken together, these findings indicate that purinergic signaling through P2Y6 receptor, followed by ERK1/2 activation, promotes the cellular repair response to γ-ray-induced DNA damage.


Subject(s)
DNA Damage , Receptors, Purinergic P2/physiology , Adenocarcinoma , Adenosine Diphosphate/pharmacology , Gamma Rays , Histones/metabolism , Humans , Isothiocyanates/pharmacology , Lung Neoplasms , MAP Kinase Signaling System/physiology , Phosphorylation , Receptors, Purinergic P2/metabolism , Thiourea/analogs & derivatives , Thiourea/pharmacology , Tumor Cells, Cultured , Uridine Triphosphate/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL